PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar.\', \'World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar.\', \'Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.\', \'Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.\', \'Department of Pathology, Sidra Medicine, Doha, Qatar.\', \'Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.\', \'Department of Genetic Medicine, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.\', \'Hamad Medical Corporation, Doha, Qatar.\', \'Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, UK.\', \'Department of Mathematics, Statistics, and Physics, Qatar University, Doha, Qatar.\', \'College of Health Sciences, QU Health, Qatar University, Doha, Qatar.\', \'Primary Health Care Corporation, Doha, Qatar.\', \'Ministry of Public Health, Doha, Qatar.\', \'Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA.\', \'Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar. lja2002@qatar-med.cornell.edu.\', \'World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar. lja2002@qatar-med.cornell.edu.\', \'Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA. lja2002@qatar-med.cornell.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41591-021-01446-y
?:doi
?:hasPublicationType
?:journal
  • Nature medicine
is ?:pmid of
?:pmid
?:pmid
  • 34244681
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 17.067
?:rankingScore_hIndex
  • 484
?:title
  • mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34244681>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34244681>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all